Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.

Ringman, John M; Sachs, Michael C; Zhou, Yan; Monsell, Sarah E; Saver, Jeffrey L; Vinters, Harry V

Ringman, John M; Sachs, Michael C; Zhou, Yan; Monsell, Sarah E; Saver, Jeffrey L; Vinters, Harry V.

Affiliation

Ringman JM; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles2Mary S. Easton Center for Alzheimer's Disease Research, University of California, Los Angeles.
Sachs MC; National Alzheimer's Coordinating Center, University of Washington, Seattle.
Zhou Y; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles2Mary S. Easton Center for Alzheimer's Disease Research, University of California, Los Angeles.
Monsell SE; National Alzheimer's Coordinating Center, University of Washington, Seattle.
Saver JL; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Vinters HV; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles2Mary S. Easton Center for Alzheimer's Disease Research, University of California, Los Angeles4Division of Neuropathology, Department of Pathology and Laborator.

JAMA Neurol ; 71(7): 878-83, 2014 Jul 01.

Article in En | MEDLINE | ID: mdl-24797962

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebral Amyloid Angiopathy / Apolipoprotein E4 / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: JAMA Neurol Year: 2014 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google